This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
439 |
4. Check minimum number of eventsNone |
439 |
5. Include endpointsNone |
439 |
6. Filter based on genotype QC (FinnGen only) |
439 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Senilitas
Similar endpoints
↥List of similar endpoints to
Senility
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 439 | 230 | 209 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.09 |
| Median age at first event (years) | 83.62 | 84.45 | 82.71 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 362
- Matched controls
- 3610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R54
ICD-10 Finland
Senility
+∞
323.0
362
*
R53
ICD-10 Finland
Malaise and fatigue
18.6
96.1
161
149
R50.9
ICD-10 Finland
Fever, unspecified
16.0
29.8
49
35
R55
ICD-10 Finland
Syncope and collapse
21.8
28.1
41
21
A28
ICPC
Limited function/disability NOS
4.2
26.6
121
386
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
21.1
171
824
N06AX11
ATC
mirtazapine; oral
3.4
20.3
122
471
R56.8
ICD-10 Finland
Other and unspecified convulsions
110.8
19.7
21
*
R42
ICD-10 Finland
Dizziness and giddiness
3.3
18.9
116
454
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
18.4
103
376
R51.80
ICD-10 Finland
Headache
13.5
17.4
30
24
L28
ICPC
Limited function/disability (L)
3.3
15.7
89
323
N06AB04
ATC
citalopram; systemic
2.9
15.0
108
459
N30.0
ICD-10 Finland
Acute cystitis
3.5
14.8
75
249
A04
ICPC
Weakness/tiredness general
3.8
14.8
68
209
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
14.0
155
842
E86
ICD-10 Finland
Volume depletion
7.5
12.0
28
40
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.3
11.7
64
223
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.4
11.3
58
193
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
11.3
107
524
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
10.9
72
285
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
10.8
133
740
N02BE01
ATC
paracetamol; systemic, rectal
2.2
10.8
249
1819
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
10.2
78
337
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
10.1
89
415
N06DX01
ATC
memantine; oral
2.9
10.0
67
265
ZXD05
NOMESCO Finland
Urgent procedure
2.3
10.0
114
604
AA1AD
NOMESCO Finland
CT of head and brain
2.5
9.8
85
393
Z29
ICPC
Social problem NOS
11.8
9.6
17
15
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
9.6
112
601
N05AH04
ATC
quetiapine; oral
3.0
9.4
55
201
N03AX16
ATC
pregabalin; oral
2.7
9.4
68
284
A29
ICPC
General symptom/complaint other
3.2
9.3
49
167
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
9.2
33
81
J01MA02
ATC
ciprofloxacin; systemic
2.1
9.2
148
908
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.1
9.2
141
850
N05AX08
ATC
risperidone; systemic
2.9
9.1
59
230
-69
ICPC
Other reason for encounter NEC
6.4
9.0
23
38
A06AD11
ATC
lactulose; oral
2.2
9.0
118
661
I95.1
ICD-10 Finland
Orthostatic hypotension
5.3
8.8
26
52
N06AB10
ATC
escitalopram; oral
3.0
8.8
53
195
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.6
8.6
65
277
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
8.3
126
746
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.2
78
378
A23
ICPC
Risk factor NOS
5.3
8.2
24
48
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
8.2
32
86
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
7.1
8.2
19
28
C03CA01
ATC
furosemide; systemic
1.9
8.1
192
1345
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
8.0
53
208
P20
ICPC
Memory disturbance
2.5
8.0
67
301
N05BA04
ATC
oxazepam; oral
2.1
8.0
100
548
N02AX02
ATC
tramadol; systemic, rectal
2.0
7.8
136
846
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.6
7.8
26
60
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
7.7
108
621
S06.0
ICD-10 Finland
Concussion
3.1
7.6
41
142
W19
ICD-10 Finland
Unspecified fall
2.8
7.5
48
186
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
7.5
69
328
R41.0
ICD-10 Finland
Disorientation, unspecified
4.1
7.4
28
73
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
7.4
202
1468
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.5
7.4
33
100
F21
ICPC
NA
11.1
7.3
13
12
F10.24
ICD-10 Finland
Alcohol depence active use
+∞
7.3
7
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
7.2
49
197
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.5
7.2
20
38
F03
ICD-10 Finland
Unspecified dementia
2.3
7.0
64
302
R60.0
ICD-10 Finland
Localized oedema
3.2
7.0
35
116
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.9
87
472
C07AB07
ATC
bisoprolol; oral
1.8
6.9
174
1221
B01AA03
ATC
warfarin; systemic
1.9
6.9
122
761
A01
ICPC
Pain general/multiple sites
3.5
6.8
30
90
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.9
6.8
40
148
S20.2
ICD-10 Finland
Contusion of thorax
4.4
6.7
23
55
N02AA05
ATC
oxycodone; systemic
2.3
6.7
64
307
J01DB01
ATC
cefalexin; oral
1.8
6.6
199
1471
Z71.8
ICD-10 Finland
Other specified counselling
2.5
6.5
51
222
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
6.5
71
361
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.9
6.5
17
30
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
4.8
6.5
20
43
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
6.5
107
645
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
6.4
69
352
K90
ICPC
Stroke/cerebrovascular accident
6.1
6.4
16
27
N30.9
ICD-10 Finland
Cystitis, unspecified
3.0
6.3
36
129
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
6.2
161
1129
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
6.2
43
176
U28
ICPC
Limited function/disability (U)
10.2
6.1
11
11
ZXA00
NOMESCO Finland
Right side
1.9
6.0
93
547
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.3
6.0
29
94
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014111) Lactate [Moles/volume] in Serum or Plasma
73
187
4.47
26.50
3.0
3.5
mmol/l
1.5
1.5
0.14
67
174
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
128
4.95
24.26
2.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
250
3.79
23.36
1.9
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
100
371
3.18
20.81
31.3
35.2
inr
1.0
1.7
—
5
37
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
79
253
3.58
20.80
1.9
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
164
796
2.68
20.76
2.2
2.1
nmol/l
76.0
80.0
0.91
151
668
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
99
377
3.09
19.62
2.0
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
139
4.28
19.30
2.0
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
60
170
3.92
18.82
1.6
2.0
g/l
0.2
0.2
0.56
47
154
(40758558) Short blood count panel - Blood
106
429
2.93
18.79
5.8
5.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
145
698
2.60
18.30
4.5
3.1
e6/l
105.2
195.5
0.38
117
541
(3030467) Casts [#/volume] in Urine by Automated count
132
615
2.63
17.73
4.3
3.0
e6/l
0.4
0.7
1.31
108
474
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
314
3.11
17.63
4.0
2.8
e6/l
2.7
2.4
0.11
57
172
(3023368) Bacteria identified in Blood by Culture
139
666
2.58
17.61
4.3
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
155
796
2.45
16.82
5.2
3.5
e6/l
145.0
152.0
0.04
121
582
(3022948) Iron [Moles/volume] in Serum or Plasma
87
336
2.97
16.64
1.9
2.1
umol/l
9.3
11.5
2.47
80
303
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
154
793
2.44
16.57
4.2
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
159
837
2.40
16.23
5.1
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
192
1097
2.32
16.22
4.9
4.8
mmol/l
1.2
1.2
0.28
172
882
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
178
997
2.31
15.63
2.5
2.0
pmol/l
85.5
89.8
0.69
104
503
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
129
632
2.47
15.31
2.7
1.9
u/l
185.0
441.7
1.21
121
582
(36304419) Bacteria [Presence] in Urine
122
589
2.47
14.90
4.1
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
99
438
2.62
14.48
6.5
3.5
ng/l
83.4
358.8
1.48
93
396
(3012095) Magnesium [Moles/volume] in Serum or Plasma
70
260
3.00
14.24
2.2
2.2
mmol/l
0.8
0.8
0.79
63
237
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
73
278
2.94
14.21
1.9
2.2
%
17.6
20.2
0.73
68
230
(3013650) Neutrophils [#/volume] in Blood by Automated count
179
1037
2.22
14.19
6.8
6.0
e9/l
4.9
4.4
1.52
156
880
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
327
2.80
14.15
3.7
2.7
e6/l
0.8
1.3
1.34
53
184
(3024561) Albumin [Mass/volume] in Serum or Plasma
168
954
2.22
13.94
3.6
3.7
g/l
32.2
34.1
3.05
148
858
(3000850) Epithelial cells [#/volume] in Urine
108
507
2.49
13.91
3.1
2.6
e6/l
5.3
5.3
0.02
94
445
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
170
978
2.20
13.59
5.0
4.2
mmol/l
1.2
1.2
0.09
158
835
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
120
606
2.34
13.06
2.9
2.1
mg/l
3.1
3.4
0.63
102
503
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
47
5.56
12.86
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
47
5.56
12.86
1.4
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
31
71
4.61
12.77
1.5
1.9
ug/l
224.2
1218.7
0.88
26
65
(3018418) pH of Serum or Plasma
123
638
2.28
12.51
3.0
3.1
ph
7.4
7.4
3.28
17
124
(3013826) Glucose [Moles/volume] in Serum or Plasma
195
1212
2.09
12.51
4.9
3.6
mmol/l
6.8
7.0
0.61
186
1105
(3014051) Protein [Presence] in Urine by Test strip
22
39
5.87
12.01
4.1
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
113
576
2.29
11.91
1.8
1.5
nmol/l
17.5
20.1
1.02
102
469
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
168
1008
2.07
11.67
5.0
4.5
umol/l
12.5
13.1
0.23
163
938
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
46
151
3.28
11.47
2.7
1.9
u/l
34.4
31.2
0.41
40
121
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
136
3.30
10.70
6.4
3.2
ml/min/173m2
50.2
55.4
0.90
21
62
(3031040) Bacteria [#/volume] in Urine by Automated count
219
1493
1.92
10.17
8.2
4.9
e6/l
7716.0
3805.0
—
6
44
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
136
791
2.03
10.02
2.8
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
83
3.79
9.66
3.5
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
145
877
1.97
9.48
4.9
4.2
e9/l
0.0
0.0
0.21
121
742
(3001604) Monocytes [#/volume] in Blood
144
872
1.96
9.36
4.9
4.1
e9/l
0.6
0.6
0.25
121
733
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
148
3.02
9.30
1.6
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
148
912
1.93
9.10
4.9
4.2
e9/l
0.2
0.2
0.17
125
789
(3019198) Lymphocytes [#/volume] in Blood
147
907
1.93
8.98
5.1
4.3
e9/l
1.5
1.8
2.63
122
784
(3019069) Monocytes/100 leukocytes in Blood
137
831
1.94
8.78
5.0
4.4
%
8.9
9.0
0.21
128
748
(3006504) Eosinophils/100 leukocytes in Blood
136
826
1.93
8.66
4.9
4.2
%
2.5
2.9
1.04
126
742
(40761535) Cells panel - Urine sediment
51
208
2.63
8.62
5.8
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
62
4.02
8.49
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
137
845
1.90
8.27
3.3
3.2
ng/l
3349.3
2834.1
0.30
116
737
(3022096) Basophils/100 leukocytes in Blood
131
802
1.90
8.06
5.1
4.1
%
0.6
0.6
0.19
120
716
(3002030) Lymphocytes/100 leukocytes in Blood
137
855
1.87
7.92
5.2
4.5
%
21.8
25.3
3.48
127
768
(3021589) Normoblasts [#/volume] in Blood
129
792
1.88
7.84
10.5
8.8
e9/l
0.0
0.0
0.02
105
640
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
87
466
2.07
7.83
3.3
2.7
mmol/l
2.5
2.5
0.27
75
391
(3027945) Reticulocytes/100 erythrocytes in Blood
59
270
2.36
7.81
2.8
2.2
%
1.7
1.7
0.07
48
233
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
216
1552
1.76
7.77
7.0
5.5
u/l
93.9
83.7
0.93
206
1398
(3001122) Ferritin [Mass/volume] in Serum or Plasma
126
782
1.85
7.34
3.4
2.4
ug/l
127.5
128.2
0.01
117
682
(3018010) Neutrophils/100 leukocytes in Blood
133
844
1.82
7.19
5.1
4.3
%
63.1
59.6
2.67
123
764
(3002385) Erythrocyte distribution width [Ratio]
207
1503
1.71
6.92
32.2
18.7
%
14.5
14.1
2.77
201
1460
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
31
112
2.89
6.58
3.6
4.9
mmol/l
24.8
25.0
0.15
25
96
(42870588) Differential panel, method unspecified - Blood
97
583
1.85
6.15
4.6
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
39
4.21
6.11
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
196
1455
1.62
5.68
6.1
4.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
32
128
2.61
5.64
1.3
1.6
nmol/l
432.4
406.9
0.22
27
104
(3032080) INR in Blood by Coagulation assay
143
984
1.67
5.58
10.4
11.0
inr
1.5
1.4
0.22
49
254
(3026782) Osmolality of Urine
82
485
1.84
5.44
3.2
2.5
mosm/kgh2o
527.0
542.9
0.35
70
414
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
250
1982
1.60
5.41
29.7
14.8
mg/l
31.7
30.0
0.26
235
1624
(3003458) Phosphate [Moles/volume] in Serum or Plasma
50
250
2.12
5.35
2.5
4.0
mmol/l
1.0
1.0
0.02
38
226
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
221
1714
1.57
5.17
26.2
15.0
ml/min/173m2
66.8
66.0
0.21
192
1388
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
224
1743
1.57
5.16
4.8
4.5
mu/l
2.0
2.1
0.51
201
1501
(3015377) Calcium [Moles/volume] in Serum or Plasma
116
770
1.68
5.14
2.9
2.6
mmol/l
2.3
2.4
0.23
98
639
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
40
3.83
5.10
1.7
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
189
1420
1.57
5.04
3.7
3.7
pmol/l
15.8
15.3
1.67
170
1231
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
195
2.21
4.97
2.5
2.3
umol/l
8.2
13.4
1.01
36
159
(3044640) Blood type and Crossmatch panel - Blood
95
608
1.71
4.79
2.8
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
37
175
2.21
4.55
3.8
4.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
50
266
1.99
4.54
3.4
4.4
kpa
4.8
5.1
1.32
43
252
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
26
105
2.56
4.52
1.5
1.4
g/l
1.6
1.6
0.03
20
91
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
449
1.77
4.49
6.1
4.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
46
239
2.03
4.46
2.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
45
233
2.03
4.40
1.3
1.3
g/l
2.6
2.6
0.02
24
128
(3003396) Base excess in Arterial blood by calculation
49
264
1.96
4.30
3.5
4.4
mmol/l
0.0
1.5
1.17
37
205
(3022621) pH of Urine by Test strip
35
166
2.20
4.29
5.9
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
46
244
1.98
4.22
2.2
3.2
ng/l
352.3
256.3
0.58
40
224
(3027801) Oxygen [Partial pressure] in Arterial blood
49
267
1.93
4.16
3.5
4.4
kpa
10.7
11.0
0.17
43
253
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
134
970
1.54
4.04
6.0
3.9
ng/l
112.1
67.8
0.26
113
752
(3019309) Folate [Moles/volume] in Red Blood Cells
91
602
1.64
4.01
2.1
1.9
nmol/l
1203.4
1200.0
0.01
70
446
(40761511) CBC panel - Blood by Automated count
243
2001
1.47
3.85
25.4
15.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
249
2062
1.47
3.82
33.1
18.9
mmol/l
138.9
139.5
1.95
243
1968
(3023103) Potassium [Moles/volume] in Serum or Plasma
249
2067
1.46
3.74
33.2
19.0
mmol/l
4.0
4.0
1.42
243
1969
(3010813) Leukocytes [#/volume] in Blood
254
2117
1.47
3.73
38.3
22.4
e9/l
7.3
7.1
0.54
246
2017
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
134
985
1.51
3.72
2.8
2.7
u/l
58.6
51.5
0.28
118
882
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
435
1.69
3.65
2.4
2.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
253
2115
1.45
3.61
38.3
22.4
e9/l
237.5
238.4
0.06
245
2025
(3024731) MCV [Entitic volume]
253
2116
1.45
3.59
38.3
22.4
fl
92.1
91.8
0.59
245
2047
(3035941) MCH [Entitic mass]
253
2116
1.45
3.59
38.2
22.3
pg
30.3
30.3
0.09
246
2047
(3026361) Erythrocytes [#/volume] in Blood
253
2116
1.45
3.59
38.4
22.5
e12/l
4.1
4.3
4.68
243
2017
(3000963) Hemoglobin [Mass/volume] in Blood
253
2117
1.45
3.58
38.8
22.6
g/l
123.8
129.5
6.26
246
2046
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
22
93
2.43
3.52
2.2
2.7
mmol/l
24.3
23.8
0.26
22
85
(3020630) Protein [Mass/volume] in Serum or Plasma
34
173
2.04
3.51
1.5
2.0
g/l
64.5
65.4
0.30
28
150
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
242
2014
1.44
3.49
11.2
8.9
u/l
21.2
22.9
0.90
229
1892
(3023520) Reticulocytes [#/volume] in Blood
36
190
1.97
3.37
3.0
2.0
e9/l
70.1
64.0
0.86
28
149
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
234
1.87
3.36
3.7
2.2
ug/l
4.4
6.0
0.52
33
187
(3003327) Ova and parasites identified in Stool by Light microscopy
10
27
3.75
3.35
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
17
66
2.63
3.23
1.6
1.8
g/l
0.8
0.9
0.04
12
50
(3004588) Protein electrophoresis panel - Serum or Plasma
27
130
2.14
3.23
1.6
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
67
2.59
3.14
1.6
1.5
g/l
3.2
3.4
—
10
52
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
50
2.85
3.09
1.3
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
16
62
2.63
3.06
1.1
1.5
g/l
35.4
35.5
—
10
49
(3025159) Blasts/100 leukocytes in Blood
25
121
2.12
2.96
4.0
3.3
%
0.0
0.3
—
7
30
(3044889) 12 lead EKG panel
171
1367
1.40
2.94
4.2
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
48
291
1.72
2.93
2.5
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
11
35
3.19
2.93
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
188
1532
1.39
2.87
37.6
20.7
g/l
328.1
330.0
1.95
182
1500
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
13
5.43
2.87
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
9
6.72
2.87
1.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
23
111
2.12
2.76
3.5
2.7
%
0.4
0.5
—
5
22
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
113
851
1.44
2.68
3.9
4.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
45
276
1.70
2.65
1.2
1.2
u/ml
0.7
1.3
0.66
15
73
(3009542) Hematocrit [Volume Fraction] of Blood
197
1636
1.36
2.61
28.9
16.9
%
35.4
36.4
0.65
133
934
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
74
2.34
2.59
1.6
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
74
2.34
2.59
1.6
1.5
g/l
3.6
3.8
—
10
50
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
74
2.34
2.59
1.6
1.5
g/l
6.6
8.1
1.02
11
51
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
69
2.36
2.49
2.6
1.9
u/ml
0.3
0.3
—
10
33
(3000330) Specific gravity of Urine by Test strip
26
137
1.95
2.49
4.5
3.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
131
1.96
2.44
4.1
3.2
%
0.4
0.8
—
7
36
(1761868) Lipid panel - Serum or Plasma
28
479
0.55
2.42
3.1
3.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
23
118
2.00
2.38
2.9
1.8
%
0.7
0.7
0.04
23
113
(3024928) Oxygen saturation in Venous blood
11
40
2.79
2.37
1.4
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
14
59
2.41
2.30
1.0
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
232
1.69
2.30
3.7
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
127
1.93
2.29
4.2
3.2
%
0.0
0.1
—
6
35
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
23
3.51
2.27
2.0
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
9
5.59
2.21
4.2
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
174
1450
1.32
2.15
4.4
3.6
mm/h
20.7
16.2
2.02
155
1287
(3044290) Cell count panel - Cerebral spinal fluid
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
127
1018
1.34
2.03
6.2
4.1
estimate
0.0
0.0
0.00
23
191
(3021601) Nitrite [Presence] in Urine by Test strip
126
1011
1.34
2.00
7.5
5.5
estimate
0.0
0.0
0.00
24
180
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
55
381
1.50
2.00
1.5
1.5
mg/l
4.3
1.4
0.52
45
296
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
70
509
1.44
2.00
2.7
2.5
u/l
30.4
37.7
0.83
63
488
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
70
2.18
1.99
1.0
1.5
g/l
11.2
10.8
—
10
59
(3035350) Ketones [Presence] in Urine by Test strip
126
1015
1.33
1.94
5.7
3.9
estimate
0.0
0.0
0.00
21
193
(4024509)
5
11
4.57
1.94
1.6
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
12
4.19
1.82
1.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
365
1.48
1.78
2.8
3.4
ug/l
0.7
0.9
0.69
33
249
(3022145) Colonoscopy Study observation
27
162
1.70
1.77
1.1
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
41
2.46
1.75
1.3
2.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
1.2
1.3
nmol/l
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
75
2.03
1.70
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
32
205
1.60
1.66
1.2
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
128
1.75
1.62
4.4
4.3
mmol/l
3.9
2.1
1.22
12
94
(3049717) Cytology report of Urine Cyto stain
17
91
1.90
1.61
2.2
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
84
1.93
1.60
2.6
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
70
2.03
1.59
1.7
2.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
28
2.52
1.45
1.4
1.4
%
51.9
55.5
—
7
28
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
39
2.33
1.43
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
29
2.43
1.39
1.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
67
1.96
1.38
2.5
3.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
47
2.15
1.33
1.1
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
46
337
1.40
1.30
3.6
3.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
34
2.37
1.29
1.8
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
18
2.79
1.28
2.0
5.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
99
1.74
1.27
2.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
55
2.02
1.27
2.6
2.7
kpa
6.7
7.6
1.50
11
45
(3029937) Albumin [Presence] in Urine by Test strip
74
592
1.30
1.19
6.9
4.0
estimate
0.0
0.0
0.00
23
180
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
80
647
1.28
1.19
5.0
5.6
ug/l
16.8
3.7
0.61
70
549
(3022806) Fractional oxyhemoglobin in Capillary blood
6
26
2.32
1.18
1.3
1.2
%
90.3
88.8
—
6
26
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
30
2.35
1.12
1.7
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
21
2.39
1.09
1.0
1.3
—
1.6
—
0
5
(3001019) Free T4 and TSH panel - Serum or Plasma
5
21
2.39
1.09
3.0
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
206
1860
1.20
1.08
4.2
4.8
mmol/l
6.1
6.1
0.18
179
1592
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
510
1.29
1.07
3.5
4.6
%
21.8
22.2
0.06
34
273
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
97
1.67
1.07
2.8
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
10
52
1.94
1.06
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
22
2.28
1.03
1.0
1.3
—
2.4
—
0
6
(3000492) Spirometry study
18
114
1.60
1.03
1.7
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
21
141
1.51
0.95
1.9
1.7
ug/g
267.1
174.6
0.35
16
103
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
52
1.74
0.92
2.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
195
1772
1.17
0.91
5.8
6.5
mmol/mol
41.4
41.9
0.28
171
1575
(4034850)
11
63
1.76
0.90
11.2
13.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
44
1.83
0.86
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
44
1.83
0.86
2.6
3.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
177
0.61
0.84
7.5
3.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
65
1.70
0.82
1.6
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
50
610
0.79
0.80
3.0
2.9
mg/l
47.8
175.9
0.62
34
388
(3002256) Pathology report gross observation
33
251
1.34
0.79
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
66
1.68
0.78
1.6
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
100
0.49
0.78
7.0
3.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
34
1.77
0.76
1.2
1.3
mmol/l
1.5
1.9
—
6
34
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
23
2.18
0.76
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
23
2.18
0.76
1.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
28
211
1.34
0.73
4.7
3.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
25
2.00
0.72
3.8
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
39
1.80
0.72
1.1
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
68
1.63
0.71
1.6
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
40
1.76
0.71
1.0
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
26
1.93
0.70
1.8
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
(3020891) Body temperature
14
94
1.50
0.66
6.6
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
55
649
0.82
0.66
3.8
3.6
mg/mmol
8.3
12.5
0.37
37
404
(3042631) Mycobacterium sp identified in Specimen
5
30
1.67
0.61
6.0
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
86
0.57
0.56
1.4
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
55
468
1.20
0.56
3.1
2.6
umol/l
340.7
8185.8
2.63
45
384
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
133
0.67
0.52
1.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
80
708
1.15
0.52
2.3
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
75
1.47
0.50
1.6
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
226
1.25
0.48
1.4
1.2
iu/ml
23.4
57.3
—
9
78
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
252
0.78
0.45
4.4
4.6
%
35.9
32.4
—
9
151
(3000494) Fungus identified in Specimen by Culture
21
165
1.28
0.45
1.4
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.0
2.7
—
—
—
0
0
(44806420)
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
34
1.47
0.40
2.8
1.9
—
5.0
—
0
5
(46235355) HIV 1 and 2 tests - Meaningful Use set
17
132
1.30
0.40
1.2
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
183
1729
1.09
0.39
3.8
4.2
mmol/l
1.4
1.5
0.29
152
1499
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
35
1.43
0.39
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
51
574
0.87
0.38
6.1
3.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
185
1753
1.09
0.37
3.9
4.3
mmol/l
4.1
4.4
2.43
159
1542
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
192
1827
1.08
0.35
4.3
4.9
mmol/l
2.3
2.5
2.60
164
1592
(1616796) Gas panel - Central venous blood
6
44
1.36
0.34
2.5
4.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
45
1.33
0.33
1.8
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
118
1.28
0.33
2.1
2.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
47
1.28
0.32
2.3
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
581
1.11
0.31
1.8
1.8
pmol/l
475.6
441.3
0.26
51
465
(3019832) Treponema pallidum Ab [Presence] in Serum
7
55
1.27
0.30
1.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
102
1.28
0.29
4.8
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
95
1.27
0.26
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
86
804
1.08
0.24
5.6
3.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
9
77
1.17
0.24
2.7
2.1
nmol/l
6.9
10.2
—
9
70
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
96
1.25
0.24
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
295
0.87
0.24
12.8
8.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
174
1672
1.06
0.23
3.5
3.8
mmol/l
1.2
1.2
0.12
145
1428
(40768806) Pleura Pathology biopsy report
5
39
1.28
0.23
1.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
56
603
0.91
0.22
3.0
2.8
mmol/l
6.2
6.6
0.28
46
495
(21494755) Public health laboratory ask at order entry panel
5
41
1.22
0.22
1.6
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
98
1.23
0.21
4.6
6.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
216
0.87
0.18
1.5
1.2
u/ml
5.0
11.7
—
9
70
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
60
1.17
0.18
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
69
1.16
0.16
1.0
1.1
u/ml
160.9
138.4
—
8
63
(3019060) Gas panel - Arterial blood
19
167
1.14
0.16
3.1
3.7
—
—
—
0
0
(3013512) EKG study
64
675
0.94
0.16
5.5
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
46
429
1.08
0.15
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
55
1.09
0.09
2.0
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
61
0.81
0.08
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
52
500
1.04
0.07
7.9
4.5
kg/l
1.0
1.0
—
5
81
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
140
0.92
0.05
1.7
1.4
—
—
—
0
0
(4035726)
14
149
0.93
0.04
1.1
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
827
0.99
0.02
7.5
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
123
1.06
0.01
1.2
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
12
114
1.05
0.00
2.0
3.0
e9/l
5.8
4.4
—
7
81
(4010399)
12
118
1.01
0.00
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
138
1.01
0.00
1.3
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.2
—
0
6
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
3.5
—
1750.0
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
35.5
—
0
6
(3035637) Corticotropin [Mass/volume] in Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.2
—
0
6
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
214.8
—
0
6
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
79
1.01
0.00
1.0
2.5
u/ml
6.9
2221.1
—
8
69
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
13.4
—
14.8
—
0
5
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
103.6
—
0
7
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
7.6
—
0
7
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SENILITY – Senility
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).